Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) PT at $36.00
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year […]
More Stories
Analysts Set Whitbread plc (LON:WTB) Target Price at GBX 2,860
Shares of Whitbread plc (LON:WTB – Get Free Report) have received an average recommendation of “Moderate Buy” from the six...
Amentum Holdings, Inc. (NYSE:AMTM) Receives Consensus Rating of “Hold” from Analysts
Shares of Amentum Holdings, Inc. (NYSE:AMTM – Get Free Report) have been given a consensus recommendation of “Hold” by the...
Endeavour Silver Corp. (TSE:EDR) Receives C$7.75 Consensus Price Target from Analysts
Endeavour Silver Corp. (TSE:EDR – Get Free Report) (NYSE:EXK) has earned an average rating of “Buy” from the five analysts...
Hut 8 Corp. (TSE:HUT) Receives Average Rating of “Strong Buy” from Brokerages
Hut 8 Corp. (TSE:HUT – Get Free Report) has been assigned a consensus recommendation of “Strong Buy” from the nine...
Société Générale Société anonyme (OTCMKTS:SCGLY) Given Average Rating of “Moderate Buy” by Analysts
Société Générale Société anonyme (OTCMKTS:SCGLY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the...
Kolibri Global Energy (NASDAQ:KGEI) Upgraded by Wall Street Zen to “Buy” Rating
Wall Street Zen upgraded shares of Kolibri Global Energy (NASDAQ:KGEI – Free Report) from a hold rating to a buy...